Hart AA - Search Results

1

Prognostic value of the serum tumour markers Cyfra 21-1 and tissue polypeptide antigen in malignant mesothelioma.

Schouwink H, Korse CM, Bonfrer JM, Hart AA, Baas P. Schouwink H, et al. Among authors: hart aa. Lung Cancer. 1999 Jul;25(1):25-32. doi: 10.1016/s0169-5002(99)00044-6. Lung Cancer. 1999. PMID: 10466859

2

Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer.

Bonfrer JM, Gaarenstroom KN, Kenter GG, Korse CM, Hart AA, Gallee MP, Helmerhorst TJ, Kenemans P. Bonfrer JM, et al. Among authors: hart aa. Gynecol Oncol. 1994 Dec;55(3 Pt 1):371-5. doi: 10.1006/gyno.1994.1309. Gynecol Oncol. 1994. PMID: 7530676

3

Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer.

Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Gallee MP, Hart AA, Müller M, Trimbos JB, Helmerhorst TJ. Gaarenstroom KN, et al. Among authors: hart aa. Cancer. 1994 Oct 15;74(8):2307-13. doi: 10.1002/1097-0142(19941015)74:8<2307::aid-cncr2820740815>3.0.co;2-x. Cancer. 1994. PMID: 7922982

4

Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.

Gaarenstroom KN, Bonfrer JM, Kenter GG, Korse CM, Hart AA, Trimbos JB, Helmerhorst TJ. Gaarenstroom KN, et al. Among authors: hart aa. Cancer. 1995 Sep 1;76(5):807-13. doi: 10.1002/1097-0142(19950901)76:5<807::aid-cncr2820760515>3.0.co;2-m. Cancer. 1995. PMID: 8625184

5

The prognostic significance of a previous malignancy in operable non-small cell lung cancer.

Koppe MJ, Zoetmulder FA, van Zandwijk N, Hart AA, Baas P, Rutgers EJ. Koppe MJ, et al. Among authors: hart aa. Lung Cancer. 2001 Apr;32(1):47-53. doi: 10.1016/s0169-5002(00)00208-7. Lung Cancer. 2001. PMID: 11282428

6

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer.

Bruning PF, Van Doorn J, Bonfrèr JM, Van Noord PA, Korse CM, Linders TC, Hart AA. Bruning PF, et al. Among authors: hart aa. Int J Cancer. 1995 Jul 28;62(3):266-70. doi: 10.1002/ijc.2910620306. Int J Cancer. 1995. PMID: 7543079

7

Insulin resistance and breast-cancer risk.

Bruning PF, Bonfrèr JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ. Bruning PF, et al. Among authors: hart aa. Int J Cancer. 1992 Oct 21;52(4):511-6. doi: 10.1002/ijc.2910520402. Int J Cancer. 1992. PMID: 1399128

8

Western life style and breast cancer risk.

Bruning PF, Bonfrèr JM, Hart AA, van Noord PA. Bruning PF, et al. Among authors: hart aa. Acta Clin Belg Suppl. 1993;15:2-5. doi: 10.1080/17843286.1993.11718344. Acta Clin Belg Suppl. 1993. PMID: 8517089 No abstract available.

9

Body measurements, estrogen availability and the risk of human breast cancer: a case-control study.

Bruning PF, Bonfrèr JM, Hart AA, van Noord PA, van der Hoeven H, Collette HJ, Battermann JJ, de Jong-Bakker M, Nooijen WJ, de Waard F. Bruning PF, et al. Among authors: hart aa. Int J Cancer. 1992 Apr 22;51(1):14-9. doi: 10.1002/ijc.2910510104. Int J Cancer. 1992. PMID: 1563834

10

Tamoxifen, serum lipoproteins and cardiovascular risk.

Bruning PF, Bonfrer JM, Hart AA, de Jong-Bakker M, Linders D, van Loon J, Nooyen WJ. Bruning PF, et al. Among authors: hart aa. Br J Cancer. 1988 Oct;58(4):497-9. doi: 10.1038/bjc.1988.248. Br J Cancer. 1988. PMID: 3207604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters